Hinge Health (HNGE) Stock Price, News & Analysis

Company Overview

Hinge Health (NYSE:HNGE) is a leading digital health company specializing in musculoskeletal (MSK) care solutions. Founded in 2015 and headquartered in San Francisco, California, the company develops technology-driven programs designed to prevent and manage chronic MSK conditions. Leveraging a combination of software, wearable sensors and clinical expertise, Hinge Health aims to improve patient outcomes while reducing healthcare costs for employers, health plans and care providers.

The company’s flagship offering is a virtual MSK therapy platform that delivers personalized exercise programs, educational content and real-time feedback through motion-tracking sensors. Participants access guided physical therapy sessions via a mobile application, connecting them with a clinical care team that includes physical therapists, health coaches and medical experts. Hinge Health’s integrated approach combines digital assessment tools, remote monitoring and one-on-one support to address back pain, joint conditions and post-surgical rehabilitation.

Hinge Health primarily serves large self-insured employers, health plans and provider networks across the United States, with select partnerships in Europe. Its clientele spans sectors such as technology, retail, manufacturing and finance, reflecting broad demand for scalable, evidence-based MSK solutions. By offering both preventive wellness programs and targeted therapeutic interventions, Hinge Health supports organizations in reducing medical claims, lowering disability leave and boosting workforce productivity.

Under the leadership of co-founders Daniel Perez (CEO) and Gabriel Mecklenburg (President), Hinge Health has grown from an early-stage startup into a publicly traded company. The executive team includes seasoned professionals from healthcare, technology and finance backgrounds, driving innovation in digital therapeutics and value-based care. With a focus on clinical research and continuous product enhancement, Hinge Health continues to expand its platform capabilities and geographic reach, positioning itself at the forefront of virtual MSK care delivery.

Key Stats

• Today's Range: $46.50 to $48.71
• 50-Day Range: N/A
• 52-Week Range: $33.42 to $52.16
• Volume: 306,079 shs
• Average Volume: 988,001 shs
• Market Capitalization: $3.67 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $49.36
• Consensus Rating: Buy

HNGE Stock Analysis - Frequently Asked Questions

How have HNGE shares performed this year?

Hinge Health's stock was trading at $40.15 at the start of the year. Since then, HNGE shares have increased by 20.0% and is now trading at $48.18.

When did Hinge Health IPO?

Hinge Health (HNGE) raised $437 million in an initial public offering on Thursday, May 22nd 2025. The company issued 13,666,000 shares at a price of $32.00 per share.

When did Hinge Health's quiet period expire?

Hinge Health's quiet period expired on Tuesday, July 1st. Hinge Health had issued 13,666,000 shares in its IPO on May 22nd. The total size of the offering was $437,312,000 based on an initial share price of $32.00. During Hinge Health's quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Hinge Health?

Shares of HNGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Confirmed): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Business Services
• Current Symbol: NYSE:HNGE
• Previous Symbol: NYSE:HNGE
• CIK: 1673743
• Web: N/A
• Phone: (415) 689-8429
• Fax: N/A
• Employees: 1,514
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Hinge Health: $49.36
• High Price Target: $60.00
• Low Price Target: $41.00
• Potential Upside/Downside: +5.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.06
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 78,020,000
• Free Float: N/A
• Market Cap: $3.64 billion
• Optionable: N/A
• Beta: N/A